ARTICLE | Company News
DBV, Genclis S.A.S., Hospices Civils de Lyon inflammation, diagnostic news
November 19, 2012 8:00 AM UTC
DBV announced it will use its Viaskin technology to develop Viaskin HDM to treat house dust mite allergy in children. The program will be conducted under ImmunAVia, a joint project with diagnostic co...